The above results suggest that macrophage-directed therapy is an important controlling factor in pancreatic cancer, derived through an unexpected mechanism in which the targeting of proliferating F4/80+ TAMs improves CD8+ T cell infiltration and promotes CD8+ T cell spatial redistribution in tumors. Here, CD8A is linked to familial pancreatic carcinoma.